drugset / Trial / NCT04715932

Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)

NCT04715932

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main aim of this study is to determine the effects of short-term treatment with hesperidin on COVID-19 symptoms in comparison with a placebo. Treatment effects will be observed through a symptoms diary that will be completed by participants throughout the study and by taking the oral temperature daily.

Timeline

Start
2021-02-18
Primary completion
2021-05-25
Completion
2021-06-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hesperidin Small molecule 1000 mg Oral